James J. Gormley - Concepedia

Author

James J. Gormley

Also Known As

J J Gormley, J. Gormley, J. J. GORMLEY, J. J. Gormley, J.J. Gormley, JAMES J. GORMLEY, James Gormley, James J Gormley, James J. Gormley, Jane Gormley

Publications

751

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)

About

James J. Gormley is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	472
2	Natural Sciences	5	5	156
3	Education	1	1	15
4	Engineering	1	1	93
5	Anesthesia	1	1	57

James J. Gormley

Publications

632

Citations

H-Index

Page 1

	Year	Citations
Selective antagonists at the opiate delta-receptor J.S. Shaw, Lynne Miller, M J Turnbull, Life Sciences Molecular PharmacologyFunctional SelectivityMedicineReceptor (Biochemistry)Pharmacotherapy	1982	170
Glass temperatures of some acrylic polymers Sonja Krause, James J. Gormley, Nicholas Roman, Journal of Polymer Science Part A General Papers EngineeringGlass-forming LiquidResponsive PolymersSoft MatterPolymers	1965	93
Enkephalin analogues eliciting analgesia after intravenous injection Anand S. Dutta, James J. Gormley, Christopher F. Hayward, Life Sciences Pain MedicineMedicineNeuropharmacologyPain ManagementPharmacotherapy	1977	57
Incorporation of trans-olefinic dipeptide isosteres into enkephalin and substance P analogues Michael T. Cox, James J. Gormley, Christopher F. Hayward, Journal of the Chemical Society Chemical Communications Trans-olefinic DipeptideBiochemistryM. T. CoxC. F. HaywardNatural Sciences	1980	55
High resolution nuclear magnetic resonance studies of the conformation of luteinizing hormone releasing hormone (LH-RH) and its component peptides Phillipus L. Wessels, J. Feeney, Harry Gregory, Journal of the Chemical Society Perkin Transactions 2 Molecular BiologyPeptide ScienceChemical BiologyProtein FoldingBiophysics	1973	35
C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl α-ketoheterocycles Stephen T. Furlong, Anand S. Dutta, Matthew Coath, Immunopharmacology Molecular PharmacologySignal TransductionC3 ActivationBiochemistryMedicine	2000	35
Anti‐inflammatory activity of c(ILDV‐NH(CH<sub>2</sub>)<sub>5</sub>CO), a novel, selective, cyclic peptide inhibitor of VLA‐4‐mediated cell adhesion Duncan Haworth, Amanda Rees, Peter J. Alcock, British Journal of Pharmacology Peptide EngineeringCell AdhesionImmune RegulationImmunologyAntigen Processing	1999	34
Conformationally restrained cyclic peptides as antaconists of luteinizing hormone-releasing hormone Anand S. Dutta, James J. Gormley, Peter F. McLachlan, Biochemical and Biophysical Research Communications Chemical BiologySignal TransductionBiochemistryMedicineNatural Sciences	1989	28
Analogs of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effects Anand S. Dutta, James J. Gormley, Anthony S. Graham, Journal of Medicinal Chemistry Peptide SciencePharmacotherapySubstance P. PeptidesSubstance PMedicinal Chemistry	1986	22
Potent cyclic peptide inhibitors of VLA-4 (?4?1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-d-Arg-d-Arg) (ZD7349) compatible with depot formulation Anand S. Dutta, James J. Gormley, Matthew Coath, Journal of Peptide Science	2000	20

Page 1